196 related articles for article (PubMed ID: 31727020)
21. Association between Texture Analysis Parameters and Molecular Biologic KRAS Mutation in Non-Mucinous Rectal Cancer.
Jo SJ; Kim SH; Park SJ; Lee Y; Son JH
Taehan Yongsang Uihakhoe Chi; 2021 Mar; 82(2):406-416. PubMed ID: 36238732
[TBL] [Abstract][Full Text] [Related]
22. HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.
Park JS; Yoon G; Kim HJ; Park SY; Choi GS; Kang MK; Kim JG; Jang JS; Seo AN
Virchows Arch; 2018 Oct; 473(4):413-423. PubMed ID: 30056472
[TBL] [Abstract][Full Text] [Related]
23. (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.
Lovinfosse P; Koopmansch B; Lambert F; Jodogne S; Kustermans G; Hatt M; Visvikis D; Seidel L; Polus M; Albert A; Delvenne P; Hustinx R
Br J Radiol; 2016 Jul; 89(1063):20160212. PubMed ID: 27146067
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.
Jalil O; Afaq A; Ganeshan B; Patel UB; Boone D; Endozo R; Groves A; Sizer B; Arulampalam T
Colorectal Dis; 2017 Apr; 19(4):349-362. PubMed ID: 27538267
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of KRAS Mutation Status in Rectal Cancer.
Jo P; König A; Schirmer M; Kitz J; Conradi LC; Azizian A; Bernhardt M; Wolff HA; Grade M; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
PLoS One; 2016; 11(4):e0153278. PubMed ID: 27064574
[TBL] [Abstract][Full Text] [Related]
26. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
[TBL] [Abstract][Full Text] [Related]
27. KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
Sideris M; Moorhead J; Diaz-Cano S; Bjarnason I; Haji A; Papagrigoriadis S
Anticancer Res; 2016 Oct; 36(10):5315-5324. PubMed ID: 27798894
[TBL] [Abstract][Full Text] [Related]
28. Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Chen YG; Chen MQ; Guo YY; Li SC; Wu JX; Xu BH
PLoS One; 2016; 11(4):e0153944. PubMed ID: 27100991
[TBL] [Abstract][Full Text] [Related]
29. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
[TBL] [Abstract][Full Text] [Related]
30. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance.
De Cecco CN; Ganeshan B; Ciolina M; Rengo M; Meinel FG; Musio D; De Felice F; Raffetto N; Tombolini V; Laghi A
Invest Radiol; 2015 Apr; 50(4):239-45. PubMed ID: 25501017
[TBL] [Abstract][Full Text] [Related]
31.
Sideris M; Moorhead J; Diaz-Cano S; Haji A; Papagrigoriadis S
Anticancer Res; 2017 Mar; 37(3):1349-1357. PubMed ID: 28314302
[TBL] [Abstract][Full Text] [Related]
32. KRAS status predicted by pretreatment MRI radiomics was associated with lung metastasis in locally advanced rectal cancer patients.
Xiang Y; Li S; Song M; Wang H; Hu K; Wang F; Wang Z; Niu Z; Liu J; Cai Y; Li Y; Zhu X; Geng J; Zhang Y; Teng H; Wang W
BMC Med Imaging; 2023 Dec; 23(1):210. PubMed ID: 38087207
[TBL] [Abstract][Full Text] [Related]
33. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.
Gollub MJ; Blazic I; Felder S; Knezevic A; Gonen M; Garcia-Aguilar J; Paty PP; Smith JJ
Eur Radiol; 2019 Mar; 29(3):1104-1113. PubMed ID: 30242504
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
35. Locally advanced rectal cancer: predicting non-responders to neoadjuvant chemoradiotherapy using apparent diffusion coefficient textures.
Liu M; Lv H; Liu LH; Yang ZH; Jin EH; Wang ZC
Int J Colorectal Dis; 2017 Jul; 32(7):1009-1012. PubMed ID: 28497403
[TBL] [Abstract][Full Text] [Related]
36. Analysis of KRAS Mutation Status Prediction Model for Colorectal Cancer Based on Medical Imaging.
Ren Z; Che J; Wu XW; Xia J
Comput Math Methods Med; 2021; 2021():3953442. PubMed ID: 34976107
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study.
Lisson CS; Lisson CG; Flosdorf K; Mayer-Steinacker R; Schultheiss M; von Baer A; Barth TFE; Beer AJ; Baumhauer M; Meier R; Beer M; Schmidt SA
Eur Radiol; 2018 Feb; 28(2):468-477. PubMed ID: 28884356
[TBL] [Abstract][Full Text] [Related]
38. Application value of biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in preoperative T staging after neoadjuvant chemoradiotherapy for rectal cancer.
Xiao Y; Xu D; Ju H; Yang C; Wang L; Wang J; Hazle JD; Wang D
Eur J Radiol; 2018 Jul; 104():20-25. PubMed ID: 29857861
[TBL] [Abstract][Full Text] [Related]
39. KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.
Clancy C; Burke JP; Coffey JC
Surg Oncol; 2013 Jun; 22(2):105-11. PubMed ID: 23473635
[TBL] [Abstract][Full Text] [Related]
40. KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis.
Peng J; Lv J; Peng J
Int J Colorectal Dis; 2021 Aug; 36(8):1781-1790. PubMed ID: 33760952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]